Clinical trial
Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers
NCT01353937 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- April 30, 2014
- Completion date
- September 30, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic ulcer